Foghorn Therapeutics Inc. - Common Stock, $0.0001 par value per share (FHTX) Institutional Ownership

13F Institutional Holders and Ownership History from Q4 2020 to Q4 2025

Type / Class
Equity / Common Stock, $0.0001 par value per share
Symbol
FHTX on Nasdaq
Shares outstanding
76,378,254
Price per share
$5.40
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
40,899,067
Total reported value
$199,997,332
% of total 13F portfolios
0%
Share change
-69,917
Value change
-$252,615
Number of holders
86
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Foghorn Therapeutics Inc. - Common Stock, $0.0001 par value per share (FHTX) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Flagship Ventures Fund V, L.P. 27% $112,194,766 20,774,885 Noubar Afeyan 09 Jan 2026
FMR LLC 10% $24,977,866 5,689,719 FMR LLC 31 Dec 2024

As of 30 Sep 2025, 86 institutional investors reported holding 40,899,067 shares of Foghorn Therapeutics Inc. - Common Stock, $0.0001 par value per share (FHTX). This represents 54% of the company’s total 76,378,254 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Foghorn Therapeutics Inc. - Common Stock, $0.0001 par value per share (FHTX) together control 52% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Flagship Pioneering Inc. 17% 12,674,120 0% 21% $61,976,446
FMR LLC 7.2% 5,474,491 -1.1% 0% $26,770,261
BVF INC/IL 6.9% 5,302,000 0% 1.1% $25,926,780
DEERFIELD MANAGEMENT COMPANY, L.P. 4.3% 3,255,514 0% 0.24% $15,919,463
RAYMOND JAMES FINANCIAL INC 3.2% 2,462,488 +4% 0% $12,041,566
BlackRock, Inc. 3% 2,259,948 +1.4% 0% $11,051,145
VANGUARD GROUP INC 2.5% 1,899,457 +0.78% 0% $9,288,344
Euclidean Capital LLC 2.1% 1,573,761 0% 3.2% $7,695,691
GEODE CAPITAL MANAGEMENT, LLC 1.1% 808,488 +0.1% 0% $3,954,505
Siren, L.L.C. 0.94% 720,720 0% 0.14% $3,524,321
STATE STREET CORP 0.83% 637,148 +17% 0% $3,115,654
Alphabet Inc. 0.66% 500,901 0% 0.1% $2,449,406
Point72 Asset Management, L.P. 0.49% 371,033 -45% 0% $1,814,351
NORTHERN TRUST CORP 0.37% 284,301 -0.84% 0% $1,390,232
Birchview Capital, LP 0.37% 281,730 -9.4% 1% $1,377,660
JACOBS LEVY EQUITY MANAGEMENT, INC 0.24% 184,063 -4.5% 0% $900,068
MILLENNIUM MANAGEMENT LLC 0.23% 178,791 +862% 0% $874,288
READYSTATE ASSET MANAGEMENT LP 0.21% 161,140 0.04% $787,975
DAFNA Capital Management LLC 0.17% 126,859 -58% 0.15% $620,341
Sio Capital Management, LLC 0.16% 122,889 0% 0.15% $600,927
RENAISSANCE TECHNOLOGIES LLC 0.15% 118,236 +89% 0% $578,174
Woodline Partners LP 0.14% 108,596 0% $531,034
SCS Capital Management LLC 0.14% 106,980 0% 0.01% $523,132
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.13% 98,184 +0.01% 0% $480,120
Bank of New York Mellon Corp 0.11% 80,477 +11% 0% $393,532

Institutional Holders of Foghorn Therapeutics Inc. - Common Stock, $0.0001 par value per share (FHTX) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 5,607 $30,278 +$557 $5.40 3
2025 Q3 40,899,067 $199,997,332 -$252,615 $4.89 86
2025 Q2 40,966,679 $192,544,370 +$2,995,463 $4.70 79
2025 Q1 40,422,738 $147,539,082 +$554,807 $3.65 89
2024 Q4 40,250,865 $189,972,345 +$1,515,315 $4.72 86
2024 Q3 39,996,016 $372,365,052 +$3,205,361 $9.31 78
2024 Q2 39,443,565 $226,852,214 +$74,393,685 $5.75 71
2024 Q1 26,459,793 $177,447,258 +$1,618,684 $6.71 67
2023 Q4 26,194,106 $168,954,975 -$3,389,727 $6.45 59
2023 Q3 26,924,936 $134,628,591 +$778,966 $5.00 61
2023 Q2 26,763,756 $188,422,208 +$3,982,788 $7.04 59
2023 Q1 26,253,067 $162,763,500 +$937,198 $6.20 61
2022 Q4 26,093,883 $166,474,381 -$1,442,468 $6.38 63
2022 Q3 26,307,921 $225,720,907 +$12,954 $8.58 60
2022 Q2 26,276,584 $357,367,427 +$18,367,020 $13.60 55
2022 Q1 24,903,791 $379,088,288 +$4,677,182 $15.23 57
2021 Q4 24,151,188 $552,334,813 +$1,462,679 $22.87 58
2021 Q3 11,606,587 $161,634,440 +$5,200,204 $13.93 44
2021 Q2 11,234,597 $119,870,494 +$2,946,090 $10.67 36
2021 Q1 10,646,057 $139,604,845 -$678,194 $13.18 43
2020 Q4 10,612,558 $212,930,838 +$187,364,837 $20.27 45